427 related articles for article (PubMed ID: 33755994)
21. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
22. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
[TBL] [Abstract][Full Text] [Related]
24. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
25. Analysis and verification of
Yang Z; Peng B; Pan Y; Gu Y
Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
[No Abstract] [Full Text] [Related]
26. Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration.
Shu L; Huang X; Cheng X; Li X
Cells; 2021 Oct; 10(10):. PubMed ID: 34685675
[TBL] [Abstract][Full Text] [Related]
27. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Xu D; Shao J; Song H; Wang J
Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
[TBL] [Abstract][Full Text] [Related]
28. Structural Insights into N
Huang J; Yin P
Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):85-98. PubMed ID: 29709557
[TBL] [Abstract][Full Text] [Related]
29. Cross-talk among writers, readers, and erasers of m
Panneerdoss S; Eedunuri VK; Yadav P; Timilsina S; Rajamanickam S; Viswanadhapalli S; Abdelfattah N; Onyeagucha BC; Cui X; Lai Z; Mohammad TA; Gupta YK; Huang TH; Huang Y; Chen Y; Rao MK
Sci Adv; 2018 Oct; 4(10):eaar8263. PubMed ID: 30306128
[TBL] [Abstract][Full Text] [Related]
30. Multiple m
Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
[TBL] [Abstract][Full Text] [Related]
31. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T
Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187
[TBL] [Abstract][Full Text] [Related]
32. N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression.
Tirumuru N; Zhao BS; Lu W; Lu Z; He C; Wu L
Elife; 2016 Jul; 5():. PubMed ID: 27371828
[TBL] [Abstract][Full Text] [Related]
33. Context-dependent functional compensation between Ythdf m
Lasman L; Krupalnik V; Viukov S; Mor N; Aguilera-Castrejon A; Schneir D; Bayerl J; Mizrahi O; Peles S; Tawil S; Sathe S; Nachshon A; Shani T; Zerbib M; Kilimnik I; Aigner S; Shankar A; Mueller JR; Schwartz S; Stern-Ginossar N; Yeo GW; Geula S; Novershtern N; Hanna JH
Genes Dev; 2020 Oct; 34(19-20):1373-1391. PubMed ID: 32943573
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
36. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m
Sun CY; Cao D; Du BB; Chen CW; Liu D
Int J Biol Sci; 2022; 18(7):2744-2758. PubMed ID: 35541906
[TBL] [Abstract][Full Text] [Related]
37. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
[TBL] [Abstract][Full Text] [Related]
38. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
[TBL] [Abstract][Full Text] [Related]
39. The Emerging Roles of RNA m
Lan Q; Liu PY; Bell JL; Wang JY; Hüttelmaier S; Zhang XD; Zhang L; Liu T
Cancer Res; 2021 Jul; 81(13):3431-3440. PubMed ID: 34228629
[TBL] [Abstract][Full Text] [Related]
40. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
